Arrowhead Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. 

CEO
Christopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees
329
Employees329
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1989
Founded1989
Employees
329
Employees329

ARWR Key Statistics

Market cap
3.50B
Market cap3.50B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
853.29K
Average volume853.29K
High today
$35.12
High today$35.12
Low today
$33.00
Low today$33.00
Open price
$33.20
Open price$33.20
Volume
968.87K
Volume968.87K
52 Week high
$84.83
52 Week high$84.83
52 Week low
$26.81
52 Week low$26.81

ARWR News

Simply Wall St 4d
Swelling losses haven't held back gains for Arrowhead Pharmaceuticals shareholders since they're up 566% over 5 years - Simply Wall St

Arrowhead Pharmaceuticals, Inc. ( ) shareholders have seen the share price descend 26% over the month. But that does not change the realty that the stock's perf...

Swelling losses haven't held back gains for Arrowhead Pharmaceuticals shareholders since they're up 566% over 5 years - Simply Wall St

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

ARWR Earnings

-$0.68
-$0.32
$0.05
$0.41
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 21, After Hours
ActualExpected Nov 21, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.